IN a healthcare system stretched by inflation and frayed by mistrust, Malaysia’s new ruling mandating the display of drug prices in private clinics and hospitals is more than a regulatory update – it’s a flashpoint in a long-brewing debate over fairness, access, and survival in medicine.
Effective May 1, the law – gazetted under the Price Control and Anti-Profiteering Act – requires all private healthcare providers to clearly display medicine prices.
Already a subscriber? Log in.
Subscribe now and receive free sooka plan for 1 month. T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
